212 related articles for article (PubMed ID: 25416551)
1. Pathological mutations H187R and E196K facilitate subdomain separation and prion protein conversion by destabilization of the native structure.
Hadži S; Ondračka A; Jerala R; Hafner-Bratkovič I
FASEB J; 2015 Mar; 29(3):882-93. PubMed ID: 25416551
[TBL] [Abstract][Full Text] [Related]
2. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
[TBL] [Abstract][Full Text] [Related]
3. Anchorless forms of prion protein - Impact of truncation on structure destabilization and prion protein conversion.
Kovač V; Hafner-Bratkovič I; Čurin Šerbec V
Biochem Biophys Res Commun; 2016 Dec; 481(1-2):1-6. PubMed ID: 27836542
[TBL] [Abstract][Full Text] [Related]
4. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
5. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
Palaniappan C; Narayanan RC; Sekar K
ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
[TBL] [Abstract][Full Text] [Related]
6. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
7. Kinetic intermediate in the folding of human prion protein.
Apetri AC; Surewicz WK
J Biol Chem; 2002 Nov; 277(47):44589-92. PubMed ID: 12356762
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydrophobic mutations in the H2-H3 subdomain of prion protein on stability and conversion in vitro and in vivo.
Hafner-Bratkovič I; Gaedtke L; Ondracka A; Veranič P; Vorberg I; Jerala R
PLoS One; 2011; 6(9):e24238. PubMed ID: 21909425
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
11. The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases?
Tian C; Dong X
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):429-34. PubMed ID: 23459557
[TBL] [Abstract][Full Text] [Related]
12. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
13. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.
Pérez DR; Damberger FF; Wüthrich K
J Mol Biol; 2010 Jul; 400(2):121-8. PubMed ID: 20460128
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
Vanik DL; Surewicz WK
J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
[TBL] [Abstract][Full Text] [Related]
15. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.
Hafner-Bratkovic I; Bester R; Pristovsek P; Gaedtke L; Veranic P; Gaspersic J; Mancek-Keber M; Avbelj M; Polymenidou M; Julius C; Aguzzi A; Vorberg I; Jerala R
J Biol Chem; 2011 Apr; 286(14):12149-56. PubMed ID: 21324909
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo.
Kong Q; Mills JL; Kundu B; Li X; Qing L; Surewicz K; Cali I; Huang S; Zheng M; Swietnicki W; Sönnichsen FD; Gambetti P; Surewicz WK
Cell Rep; 2013 Jul; 4(2):248-54. PubMed ID: 23871665
[TBL] [Abstract][Full Text] [Related]
17. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
[TBL] [Abstract][Full Text] [Related]
18. The unfolding of the prion protein sheds light on the mechanisms of prion susceptibility and species barrier.
Robinson PJ; Pinheiro TJ
Biochemistry; 2009 Sep; 48(36):8551-8. PubMed ID: 19655812
[TBL] [Abstract][Full Text] [Related]
19. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
20. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
Downing DT; Lazo ND
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]